Sermorelin 10mg
Synthetic GHRH analogue studied for pituitary signaling, growth hormone regulatory pathways, and endocrine research models.
Compound Overview
Sermorelin is a synthetic peptide analogue representing the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It is studied in laboratory environments for its interaction with GHRH receptors in the anterior pituitary and its role in endocrine signaling pathways associated with growth hormone regulation.
In experimental research models, Sermorelin is commonly evaluated for receptor-mediated signaling activity, pulsatile growth hormone pathway dynamics, and downstream endocrine feedback mechanisms. Studies often investigate its involvement in pituitary communication systems, IGF-related signaling networks, and peptide-driven hormonal regulation under controlled laboratory conditions.
Pituitary Signaling Research
Studied for activation of GHRH receptors involved in pituitary communication and growth hormone pathway signaling.
Endocrine Pathway Studies
Frequently evaluated in laboratory models examining GH regulatory signaling, IGF-related pathways, and hormonal feedback systems.
Laboratory Classification
Classified as a synthetic GHRH analogue for experimental and analytical endocrine research applications.
Product Specifications
- Product Name: Sermorelin
- Peptide Type: Synthetic GHRH analogue
- Structure: GHRH (1-29)
- Quantity: 10mg per vial
- Form: Lyophilized peptide powder
- Research Focus: Pituitary and growth hormone pathway signaling
- Intended Use: Research use only






Reviews
There are no reviews yet.